While many of us associate hearing aids with our grandfather sitting in a rocking chair trying to adjust the sound levels, today’s high-tech hearing aids are wireless, virtually undetectable and now for the first time, can be controlled right through your iPhone.
Beltone, one of the world’s largest manufacturers of hearing devices, recently announced the first–ever ‘Made for iPhone’ hearing aid – Beltone First. The ground–breaking device with iPhone capabilities allows consumers to receive clear, clean sound streamed directly from an iPhone, iPad or iPod touch.
To view the multimedia news release, go to: http://www.multivu.com/mnr/7213351-beltone-better-hearing-and-speech-month-iphone-hearing-aid-s
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
SunCulture Solar Inc. announces the launch of SolPad™, a new series of disruptive energy products designed to be the most advanced integrated-home or off-grid solar energy products in the world.
The SolPad’s integrated solar panel combines multiple patented technologies into a single beautiful device, including breakthrough battery storage, an innovative inverter system and intelligent software that engages and interacts with the user, giving them an unparalleled personal energy experience that gamifies energy distribution, delivery and usage.
SolPad is truly the world’s first fully integrated solar energy solution created for the modern smart home and sustainably minded global citizen.
To view the multimedia release go to:
http://www.multivu.com/players/English/7930451-sunculture-solar-solpad-energy/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
More and more work is being done using personal mobile devices and employees expect employers to keep personal information privateMobileIron on those devices, according to new research from MobileIron (NASDAQ: MOBL). The 2015 MobileIron Trust Gap Survey, released today, examines the privacy expectations workers have when using a mobile device for work. TheMobileIron online research conducted by Harris PollMobileIron on behalf of MobileIron surveyed more than 3,500 employed adults who use a mobile device for work in France, Germany, Japan, Spain, the UK, and the US (“workers”).
“Mobile workers, especially younger workers, have an expectation of privacy when using mobile devices for work. Many would leave their jobs if their employer could see personal informationMobileIron on their device,” said Ojas Rege, Vice President, Strategy, MobileIron. “In a world where smartphones contain increasing amounts of sensitive personal data, CIOs must remember that every device is a mixed-use device and must protect employee privacy as fiercely as corporate security.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423152-mobileiron-survey-mobile-device-privacy/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
More than 33 years after the popular American TV show Knight Rider showed David ‘The Hoff’ Hasselhoff talking to his car KITT, Volvo and Microsoft are launching a wearable-enabled voice control system.
Volvo owners will be able to talk to their car via their Microsoft Band 2, allowing them to instruct their vehicle to perform tasks including, setting the navigation, starting the heater, locking the doors, flashing the lights or sounding the horn via Volvo’s mobile app Volvo on Call and the connected wearable device.
In November 2015 Volvo and Microsoft announced their high-profile collaboration with the first automotive application of HoloLens technology. HoloLens is the world’s first fully untethered holographic computer, which could be used in future to redefine how customers first encounter, explore and even buy car. Now the two companies are delivering remote voice control for Volvo cars via the Microsoft Band 2 as another proof-point in their ambition to jointly develop next generation automotive technologies.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7717752-volvo-cars-microsoft-enable-people-to-talk/
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
https://nationlife.net/enjoy-eating-without-the-fear-of-choking-with-lifevac-review/
LifeVac is a patented life-saving device that is proven to be the most effective way to help a child or adult during a choking emergency.
Place LifeVac over the mouth and nose to create a seal. The one-way valve prevents air from pushing food or objects downward when pressed. Then simply pull to create a one-way suction to remove the lodged food or object in seconds.
LifeVac gives you peace of mind knowing you’re always prepared and your loved ones are protected – because every second matter.
Recommended by hundreds of doctors and medical professionals around the world. Over 100,000 sold in over 40 countries and counting!
Is your life or your child’s life, worth LESS than 100 bucks to you? This product is absolutely worth every penny. And I’ll be still very happy to have bought it, even if I don’t ever get to use it. I know it is there if I ever need it. This thing is absolutely fantastic. I’ve practiced a few times and from what I saw, it can very well save a life, in those critical few minutes you have, before the person becomes so deprived from oxygen and ultimately dies. Very easy to use. I’m grateful for it.
Always Be Prepared. Get LifeVac Today.
Reply, specialises in the design and implementation of solutions based on new communication channels and digital media, announces Breed Reply (www.breedreply.com), a new Reply advanced incubator for funding, accelerating and supporting the growth and establishment of ideas and start-ups around the Internet of Things (IoT) across Europe and the USA.
Breed Reply has already been active in setting up a growth project with Xmetrics (www.swim-xmetrics.com), a company that offers an innovative device for swimmers. Xmetrics uses sensors, electronic components and software via mobile devices, to enhance the training sessions of professional and amateur swimmers, analysing their main biometric parameters and their real time performance. Breed Reply has signed a "term sheet" for an investment of £675,000 for , 30% of XMetrics.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762565-reply-launches-breed-funding/
Huawei, a leading global information and communications technology solutions provider, today launched the Huawei P8 lite in the U.S., making it possible for U.S. consumers to have premium design and features at an accessible price. Available for just $249.99 USD, the P8 lite will be available as an unlocked device, giving consumers the option to take their phone to the network* of their choice.
“With a perfect balance of style, functionality and value, the P8 lite gives consumers a premium yet easily accessible device and experience,” said Mr. Zhiqiang Xu, President of Huawei Device USA. “We are expanding our smartphone, wearable and tablet portfolio to meet U.S. consumers’ needs and are committed to delivering the right devices at the right prices with a tremendous consumer experience.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7052351-huawei-p8-lite/
As called for in the President’s Cybersecurity National Action Plan, the White House, the National Cyber Security Alliance (NCSA) and more than 35 companies and NGOs today announced a new internet safety and security campaign, “Lock Down Your Login,” to empower Americans to better protect their online accounts. The goal is to encourage a move beyond usernames and passwords to a widespread adoption of strong authentication for key online accounts. The majority of Americans (72 percent) believe their accounts are secure with just usernames and passwords. Usernames and passwords simply are not enough; hackers and cybercriminals continue to evolve their attack techniques, and users must improve their security to better protect their accounts.
The campaign is launching at a time when Americans are more connected than ever: 73 percent go online daily, and one in five are constantly connected. Coupled with increased connectivity are high levels of concern about identity theft, device security and risks such as phishing. In fact, a recent NCSA/Microsoft study found that preventing identity theft is the top online safety topic that both U.S. adults and teens (ages 13-17) would like to learn more about. Additionally, teens reported that unauthorized account access is their top online safety concern. Although Americans consistently express high levels of concern about identity theft, device security and risks such as phishing, many are either not aware or not using widely available, simple technologies to better secure their online accounts. Americans expect the cybersecurity community to help solve the problem. In another study, 78 percent of Americans reported they strongly or somewhat agree that government, industry and other stakeholders should work to find new ways of securing accounts beyond the password.
To view the multimedia release go to:
http://www.multivu.com/players/English/7934951-ncsa-lock-down-your-login-cyber-security/
